Mihir Parikh has been appointed as Director – Commercial Excellence, BD & Strategy at AstraZeneca India, marking a significant leadership movement in the life sciences and healthcare sector. In this strategic role, he will lead initiatives focused on commercial excellence, business development, and corporate strategy, further strengthening the organization’s growth ambitions and market leadership.
With over 15 years of experience across oncology marketing, sales leadership, product launches, market access, and commercial strategy, Mihir has built a distinguished career spanning domestic and international markets. His expertise in driving high-impact commercial initiatives and delivering business growth has established him as a respected leader in the pharmaceutical industry.
Prior to this appointment, Mihir served as the Breast Cancer Franchise Lead at AstraZeneca India, where he played a pivotal role in driving portfolio growth and enhancing launch readiness
across key therapies. Earlier in his career, he held impactful leadership and commercial roles at Novartis and Roche, where he gained extensive experience in oncology marketing, brand management, commercial strategy, and market development.
Before joining AstraZeneca, Mihir also contributed to organizations including Wockhardt Ltd., Laurus Labs, and Technip, building a diverse foundation across pharmaceuticals, operations, and process engineering. Backed by broad industry expertise and a proven leadership track record, he is well positioned to strengthen AstraZeneca India’s commercial capabilities and support its long-term strategic growth.